BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16131808)

  • 1. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
    Mortier S; Faict D; Lameire NH; De Vriese AS
    Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
    Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
    Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
    Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of peritoneal dialysis solutions on peritoneal host defense.
    Mortier S; Lameire NH; De Vriese AS
    Perit Dial Int; 2004; 24(2):123-38. PubMed ID: 15119633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
    ter Wee PM; Beelen RH; van den Born J
    Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
    MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
    J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
    Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
    Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
    Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.